Overview

Antiproteinuric Effects of Liraglutide Treatment

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the effect of Liraglutide on albuminuria in type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Steno Diabetes Center
Steno Diabetes Center Copenhagen
Collaborator:
Novo Nordisk A/S
Treatments:
Liraglutide